וירמיון תרחיף ישראל - עברית - Ministry of Health

וירמיון תרחיף

boehringer ingelheim israel ltd. - nevirapine anhydrous (as hemihydrate) - תרחיף - nevirapine anhydrous (as hemihydrate) 50 mg / 5 ml - nevirapine - nevirapine - for use in combination with other antiretroviral agents for the treatment of hiv-1 infection.

טיאסר 50 מ"ג ישראל - עברית - Ministry of Health

טיאסר 50 מ"ג

bioavenir ltd - losartan as potassium 50 mg - tablets - losartan - hypertension: losartan is indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to tiasar is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrphy. the benefit of tiasar on the primary deposite end poin

טיאסר 100 מ"ג ישראל - עברית - Ministry of Health

טיאסר 100 מ"ג

bioavenir ltd - losartan as potassium 100 mg - tablets - losartan - hypertension: losartan is indicated for the treatment of heart failure ( nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to tiasar is not recommended. renal protection in type - 2 diabetic patients with proteinuria: losartan is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease ( need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrphy. losartan is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventricular hypertrphy. the benefit of tiasar on the primary deposite end poin

סטאבניר ישראל - עברית - Ministry of Health

סטאבניר

bioavenir ltd - pravastatin sodium 40 mg - tablets - pravastatin - pravastatin is indicated as a component of multiple risk factor intervention in those individuals at increased risk for atherosclerotic vascular disease due to hypercholesterolemia . pravastatin should be used in addition to a diet restricted in saturated fat and cholesterol when the response to diet and other nonpharmacological measures alone has been inadequate. *primary prevention of coronary events: in hypercholesterolemic patients whthout clinically evident coronary heart disease pravastatin is indicated to: - reduce the risk of myocardial infarcton. - reduce the risk for revascularization. - reduce the risk of deaths due to cardiovascular causes with no increase in deaths from non-cardiovascular causes. *secondary prevention of cardiovascular events: atherosclerosis: in hypercholesterolemic patients with clinically evident coronary artery disease including prior mi pravastatin is indicated to: - slow the progression of coronary atherosclerosis. - reduce the risk of acute coronary events. myocardial infa

לטרוזול פרמוז ישראל - עברית - Ministry of Health

לטרוזול פרמוז

bioavenir ltd, israel - letrozole - טבליות מצופות פילם - letrozole 2.5 mg - letrozole - letrozole - letrozole farmoz tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: letrozole farmoz is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

אלנדרובניר ישראל - עברית - Ministry of Health

אלנדרובניר

bioavenir ltd - alendronic acid as sodium 70 mg - tablets - alendronic acid - alendronate bioavenir is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures) .

סרום אנטי אדמומיות ישראל - עברית - Ministry of Health

סרום אנטי אדמומיות

ג'יג'י מעבדות קוסמטיקה בעמ - אנטי אדמומיות

PCA סרום רטינול לעור ישראל - עברית - Ministry of Health

pca סרום רטינול לעור

ג'יג'י מעבדות קוסמטיקה בעמ - שיפור מראה העור

ג'ל לטיפול בפצעונים ישראל - עברית - Ministry of Health

ג'ל לטיפול בפצעונים

ג'יג'י מעבדות קוסמטיקה בעמ - טיפול בפצעונים

PCA סי סטרנף 15% ישראל - עברית - Ministry of Health

pca סי סטרנף 15%

ג'יג'י מעבדות קוסמטיקה בעמ - הזנה לפנים